Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	asparagine-tRNA ligase activity	NARS1 NARS2	1.08e-05	2	66	2	GO:0004816
GeneOntologyMolecularFunction	5-diphosphoinositol pentakisphosphate 1-kinase activity	PPIP5K1 PPIP5K2	1.08e-05	2	66	2	GO:0033857
GeneOntologyMolecularFunction	nitric-oxide synthase activity	NOS1 NOS3	3.22e-05	3	66	2	GO:0004517
GeneOntologyMolecularFunction	tetrahydrobiopterin binding	NOS1 NOS3	6.43e-05	4	66	2	GO:0034617
GeneOntologyMolecularFunction	inositol hexakisphosphate 3-kinase activity	PPIP5K1 PPIP5K2	6.43e-05	4	66	2	GO:0052724
GeneOntologyMolecularFunction	inositol hexakisphosphate 1-kinase activity	PPIP5K1 PPIP5K2	6.43e-05	4	66	2	GO:0052723
GeneOntologyMolecularFunction	inositol hexakisphosphate 5-kinase activity	PPIP5K1 PPIP5K2	1.07e-04	5	66	2	GO:0000832
GeneOntologyMolecularFunction	diphosphoinositol pentakisphosphate kinase activity	PPIP5K1 PPIP5K2	1.07e-04	5	66	2	GO:0000829
GeneOntologyMolecularFunction	inositol hexakisphosphate kinase activity	PPIP5K1 PPIP5K2	1.07e-04	5	66	2	GO:0000828
GeneOntologyMolecularFunction	inositol-1,3,4,5,6-pentakisphosphate kinase activity	PPIP5K1 PPIP5K2	1.07e-04	5	66	2	GO:0000827
GeneOntologyMolecularFunction	ligase activity, forming carbon-oxygen bonds	MARS2 NARS1 NARS2	3.61e-04	42	66	3	GO:0016875
GeneOntologyMolecularFunction	aminoacyl-tRNA ligase activity	MARS2 NARS1 NARS2	3.61e-04	42	66	3	GO:0004812
GeneOntologyMolecularFunction	arginine binding	NOS1 NOS3	3.82e-04	9	66	2	GO:0034618
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	CYP11B1 CYP26C1 OGFOD2 NOS1 NOS3	4.55e-04	194	66	5	GO:0016705
GeneOntologyMolecularFunction	monooxygenase activity	CYP11B1 CYP26C1 NOS1 NOS3	5.71e-04	115	66	4	GO:0004497
GeneOntologyMolecularFunction	inositol phosphate kinase activity	PPIP5K1 PPIP5K2	5.81e-04	11	66	2	GO:0180030
GeneOntologyMolecularFunction	cadmium ion binding	NOS1 NOS3	6.95e-04	12	66	2	GO:0046870
GeneOntologyMolecularFunction	FMN binding	NOS1 NOS3	1.25e-03	16	66	2	GO:0010181
GeneOntologyMolecularFunction	catalytic activity, acting on a tRNA	MARS2 POP5 NARS1 NARS2	1.32e-03	144	66	4	GO:0140101
GeneOntologyMolecularFunction	transition metal ion binding	RTL3 CYP11B1 CYP26C1 OGFOD2 ADAMTS20 KMT2A NUDT8 ZNF593 NOS1 NOS3 ZCCHC3	1.67e-03	1189	66	11	GO:0046914
GeneOntologyMolecularFunction	heme binding	CYP11B1 CYP26C1 NOS1 NOS3	1.69e-03	154	66	4	GO:0020037
GeneOntologyMolecularFunction	tetrapyrrole binding	CYP11B1 CYP26C1 NOS1 NOS3	2.13e-03	164	66	4	GO:0046906
GeneOntologyMolecularFunction	fibroblast growth factor receptor binding	FGF2 FGF9	4.12e-03	29	66	2	GO:0005104
GeneOntologyBiologicalProcess	asparaginyl-tRNA aminoacylation	NARS1 NARS2	2.58e-05	3	61	2	GO:0006421
GeneOntologyCellularComponent	I-kappaB/NF-kappaB complex	NFKB1 NFKB2	5.69e-05	4	65	2	GO:0033256
MousePheno	abnormal cerebral blood flow rate	NOS1 NOS3	1.46e-05	2	54	2	MP:0031182
MousePheno	abnormal brain blood flow rate	NOS1 NOS3	4.38e-05	3	54	2	MP:0031179
Domain	IPT	NFKB1 NFKB2 PKHD1L1 PLXNB3	2.35e-06	27	66	4	SM00429
Domain	IPT	NFKB1 NFKB2 PKHD1L1 PLXNB3	4.75e-06	32	66	4	IPR002909
Domain	CAPS	CADPS CADPS2	1.23e-05	2	66	2	IPR033227
Domain	Asn-tRNA-ligase	NARS1 NARS2	1.23e-05	2	66	2	IPR004522
Domain	-	NOS1 NOS3	3.68e-05	3	66	2	3.90.340.10
Domain	NO_synthase	NOS1 NOS3	3.68e-05	3	66	2	PF02898
Domain	NOS_N	NOS1 NOS3	3.68e-05	3	66	2	IPR004030
Domain	NOS	NOS1 NOS3	3.68e-05	3	66	2	PS60001
Domain	NOS_euk	NOS1 NOS3	3.68e-05	3	66	2	IPR012144
Domain	Asp/Asn-tRNA-synth_IIb	NARS1 NARS2	7.35e-05	4	66	2	IPR002312
Domain	aa-tRNA-synt_II-like	NARS1 NARS2	1.22e-04	5	66	2	IPR018150
Domain	RHD_CS	NFKB1 NFKB2	1.22e-04	5	66	2	IPR030492
Domain	aa-tRNA-synt_II	NARS1 NARS2	1.22e-04	5	66	2	IPR004364
Domain	IPT_NFkappaB	NFKB1 NFKB2	1.22e-04	5	66	2	IPR033926
Domain	tRNA-synt_2	NARS1 NARS2	1.22e-04	5	66	2	PF00152
Domain	DUF1041	CADPS CADPS2	1.22e-04	5	66	2	SM01145
Domain	TIG	NFKB1 PKHD1L1 PLXNB3	1.77e-04	31	66	3	PF01833
Domain	Acid_Pase_AS	PPIP5K1 PPIP5K2	1.83e-04	6	66	2	IPR033379
Domain	FAD_binding_1	NOS1 NOS3	1.83e-04	6	66	2	PF00667
Domain	FAD-binding_1	NOS1 NOS3	1.83e-04	6	66	2	IPR003097
Domain	-	NOS1 NOS3	1.83e-04	6	66	2	1.20.990.10
Domain	NADPH_Cyt_P450_Rdtase_dom3	NOS1 NOS3	1.83e-04	6	66	2	IPR023173
Domain	DUF1041	CADPS CADPS2	2.55e-04	7	66	2	PF06292
Domain	Munc13_1	CADPS CADPS2	2.55e-04	7	66	2	IPR014770
Domain	HIS_ACID_PHOSPHAT_2	PPIP5K1 PPIP5K2	2.55e-04	7	66	2	PS00778
Domain	CAPS_dom	CADPS CADPS2	2.55e-04	7	66	2	IPR010439
Domain	MHD1	CADPS CADPS2	2.55e-04	7	66	2	PS51258
Domain	HIS_ACID_PHOSPHAT_1	PPIP5K1 PPIP5K2	2.55e-04	7	66	2	PS00616
Domain	His_Pase_clade-2	PPIP5K1 PPIP5K2	3.40e-04	8	66	2	IPR000560
Domain	FLAVODOXIN_LIKE	NOS1 NOS3	3.40e-04	8	66	2	PS50902
Domain	Flavodoxin/NO_synth	NOS1 NOS3	3.40e-04	8	66	2	IPR008254
Domain	His_Phos_2	PPIP5K1 PPIP5K2	3.40e-04	8	66	2	PF00328
Domain	Flavdoxin-like	NOS1 NOS3	3.40e-04	8	66	2	IPR001094
Domain	Flavodoxin_1	NOS1 NOS3	3.40e-04	8	66	2	PF00258
Domain	Ig_E-set	NFKB1 NFKB2 PKHD1L1 PLXNB3	5.02e-04	104	66	4	IPR014756
Domain	RHD_dimer	NFKB1 NFKB2	5.43e-04	10	66	2	IPR032397
Domain	RHD_dimer	NFKB1 NFKB2	5.43e-04	10	66	2	PF16179
Domain	NFkB/Dor	NFKB1 NFKB2	5.43e-04	10	66	2	IPR000451
Domain	REL_1	NFKB1 NFKB2	5.43e-04	10	66	2	PS01204
Domain	RHD_DNA_bind_dom	NFKB1 NFKB2	5.43e-04	10	66	2	IPR011539
Domain	Flavoprotein-like_dom	NOS1 NOS3	5.43e-04	10	66	2	IPR029039
Domain	RHD_DNA_bind	NFKB1 NFKB2	5.43e-04	10	66	2	PF00554
Domain	Flavoprot_Pyr_Nucl_cyt_Rdtase	NOS1 NOS3	5.43e-04	10	66	2	IPR001709
Domain	REL_2	NFKB1 NFKB2	5.43e-04	10	66	2	PS50254
Domain	-	NFKB1 NFKB2	5.43e-04	10	66	2	2.60.40.340
Domain	-	NOS1 NOS3	5.43e-04	10	66	2	3.40.50.360
Domain	OxRdtase_FAD/NAD-bd	NOS1 NOS3	7.93e-04	12	66	2	IPR001433
Domain	tRNA_anti-codon	NARS1 NARS2	7.93e-04	12	66	2	PF01336
Domain	NAD_binding_1	NOS1 NOS3	7.93e-04	12	66	2	PF00175
Domain	NA-bd_OB_tRNA	NARS1 NARS2	7.93e-04	12	66	2	IPR004365
Domain	p53-like_TF_DNA-bd	EOMES NFKB1 NFKB2	8.70e-04	53	66	3	IPR008967
Domain	aa-tRNA-synth_II	NARS1 NARS2	1.81e-03	18	66	2	IPR006195
Domain	AA_TRNA_LIGASE_II	NARS1 NARS2	1.81e-03	18	66	2	PS50862
Domain	Fd_Rdtase_FAD-bd	NOS1 NOS3	2.02e-03	19	66	2	IPR017927
Domain	FAD_FR	NOS1 NOS3	2.02e-03	19	66	2	PS51384
Domain	Riboflavin_synthase-like_b-brl	NOS1 NOS3	2.02e-03	19	66	2	IPR017938
Domain	His_PPase_superfam	PPIP5K1 PPIP5K2	2.24e-03	20	66	2	IPR029033
Domain	-	PPIP5K1 PPIP5K2	2.24e-03	20	66	2	3.40.50.1240
Domain	-	CD1B NFKB1 NFKB2 HAPLN4 KIR3DL2 PKHD1L1 PLXNB3 SEMA3E	2.26e-03	663	66	8	2.60.40.10
Domain	FGF	FGF2 FGF9	2.71e-03	22	66	2	SM00442
Domain	FGF	FGF2 FGF9	2.71e-03	22	66	2	PF00167
Domain	HBGF_FGF	FGF2 FGF9	2.71e-03	22	66	2	PS00247
Domain	Fibroblast_GF_fam	FGF2 FGF9	2.71e-03	22	66	2	IPR002209
Domain	IL-1_fam/FGF_fam	FGF2 FGF9	2.97e-03	23	66	2	IPR028142
Domain	zf-CCHC	RTL3 ZCCHC3	2.97e-03	23	66	2	PF00098
Domain	Ig-like_fold	CD1B NFKB1 NFKB2 HAPLN4 KIR3DL2 PKHD1L1 PLXNB3 SEMA3E	3.33e-03	706	66	8	IPR013783
Domain	-	RTL3 ZCCHC3	3.78e-03	26	66	2	4.10.60.10
Domain	DEATH	NFKB1 NFKB2	4.08e-03	27	66	2	SM00005
Domain	Sema	PLXNB3 SEMA3E	5.35e-03	31	66	2	SM00630
Domain	Semap_dom	PLXNB3 SEMA3E	5.35e-03	31	66	2	IPR001627
Domain	Sema	PLXNB3 SEMA3E	5.35e-03	31	66	2	PF01403
Domain	SEMA	PLXNB3 SEMA3E	5.35e-03	31	66	2	PS51004
Domain	Death	NFKB1 NFKB2	6.05e-03	33	66	2	PF00531
Domain	ZF_CCHC	RTL3 ZCCHC3	6.79e-03	35	66	2	PS50158
Pathway	REACTOME_OTHER_SEMAPHORIN_INTERACTIONS	ITGA1 PLXNB3 SEMA3E	3.04e-05	19	46	3	M10959
Pathway	PID_IL12_2PATHWAY	EOMES SPHK2 NFKB1 NFKB2	4.82e-05	62	46	4	M54
Pathway	WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19	NFKB1 NOS1 NOS3	1.12e-04	29	46	3	M40051
Pathway	REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION	NFKB1 NFKB2	2.16e-04	7	46	2	MM14930
Pathway	REACTOME_IKBA_VARIANT_LEADS_TO_EDA_ID	NFKB1 NFKB2	2.16e-04	7	46	2	M27463
Pathway	REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION	NFKB1 NFKB2	2.16e-04	7	46	2	M27227
Pathway	WP_EFFECTS_OF_NITRIC_OXIDE	NOS1 NOS3	2.88e-04	8	46	2	M39677
Pathway	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS	MARS2 NARS1 NARS2	3.18e-04	41	46	3	M14691
Pathway	REACTOME_TRNA_AMINOACYLATION	MARS2 NARS1 NARS2	3.41e-04	42	46	3	M456
Pathway	REACTOME_INTERLEUKIN_1_PROCESSING	NFKB1 NFKB2	3.70e-04	9	46	2	M27383
Pathway	REACTOME_INTERLEUKIN_1_PROCESSING	NFKB1 NFKB2	3.70e-04	9	46	2	MM15129
Pathway	REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES	NFKB1 NFKB2 KMT2A	4.47e-04	46	46	3	MM14933
Pathway	REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL	PPIP5K1 PPIP5K2	4.61e-04	10	46	2	MM14709
Pathway	REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL	PPIP5K1 PPIP5K2	4.61e-04	10	46	2	M27051
Pathway	WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION	NFKB1 NOS1 NOS3	4.77e-04	47	46	3	M39531
Pathway	PID_ANGIOPOIETIN_RECEPTOR_PATHWAY	NFKB1 FGF2 NOS3	5.39e-04	49	46	3	M92
Pathway	REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1	FGF2 FGF9	5.62e-04	11	46	2	M675
Pathway	WP_INCLUSION_BODY_MYOSITIS	NFKB1 NFKB2	5.62e-04	11	46	2	M42545
Pathway	REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION	FGF2 FGF9	6.73e-04	12	46	2	MM14728
Pathway	REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE	NOS1 NOS3	7.94e-04	13	46	2	MM15015
Pathway	REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS	NFKB1 NFKB2	7.94e-04	13	46	2	MM14616
Pathway	WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS	NOS1 NOS3	7.94e-04	13	46	2	M39894
Pathway	REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION	FGF2 FGF9	7.94e-04	13	46	2	M1087
Pathway	REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION	FGF2 FGF9	7.94e-04	13	46	2	M27061
Pathway	REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION	FGF2 FGF9	7.94e-04	13	46	2	MM14723
Pathway	REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION	FGF2 FGF9	7.94e-04	13	46	2	MM14727
Pathway	REACTOME_OTHER_SEMAPHORIN_INTERACTIONS	PLXNB3 SEMA3E	9.25e-04	14	46	2	MM15047
Pathway	REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION	FGF2 FGF9	9.25e-04	14	46	2	M27065
Pathway	WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS	SPHK2 NFKB1	9.25e-04	14	46	2	M45553
Pathway	WP_ECTODYSPLASIN_A_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT	NFKB1 NFKB2	9.25e-04	14	46	2	MM15847
Pathway	REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION	NFKB1 NFKB2	9.25e-04	14	46	2	MM15641
Pathway	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4	FGF2 FGF9	1.06e-03	15	46	2	M27509
Pathway	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4	FGF2 FGF9	1.06e-03	15	46	2	MM15235
Pathway	WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING	NFKB1 NFKB2 FGF2 NOS1	1.10e-03	140	46	4	M42572
Pathway	REACTOME_SEMAPHORIN_INTERACTIONS	ITGA1 PLXNB3 SEMA3E	1.18e-03	64	46	3	M7923
Pathway	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1	FGF2 FGF9	1.21e-03	16	46	2	M48007
Pathway	WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS	NFKB1 NOS1	1.21e-03	16	46	2	M42567
Pathway	REACTOME_THE_NLRP3_INFLAMMASOME	NFKB1 NFKB2	1.21e-03	16	46	2	M1063
Pathway	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1	FGF2 FGF9	1.21e-03	16	46	2	MM15233
Pathway	BIOCARTA_GCR_PATHWAY	NFKB1 NOS3	1.37e-03	17	46	2	M10066
Pathway	REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION	FGF2 FGF9	1.37e-03	17	46	2	MM17066
Pathway	BIOCARTA_GCR_PATHWAY	NFKB1 NOS3	1.37e-03	17	46	2	MM1372
Pathway	REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1	NFKB1 NFKB2	1.37e-03	17	46	2	M583
Pathway	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2	FGF2 FGF9	1.37e-03	17	46	2	MM15234
Pathway	REACTOME_SHC_MEDIATED_CASCADE_FGFR3	FGF2 FGF9	1.37e-03	17	46	2	MM15244
Pathway	REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES	NFKB1 NFKB2 KMT2A	1.53e-03	70	46	3	M27231
Pathway	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2	FGF2 FGF9	1.54e-03	18	46	2	M27508
Pathway	REACTOME_SHC_MEDIATED_CASCADE_FGFR3	FGF2 FGF9	1.54e-03	18	46	2	M27518
Pathway	REACTOME_PI_3K_CASCADE_FGFR3	FGF2 FGF9	1.54e-03	18	46	2	M27521
Pathway	REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION	FGF2 FGF9	1.54e-03	18	46	2	M1092
Pathway	REACTOME_PI_3K_CASCADE_FGFR3	FGF2 FGF9	1.54e-03	18	46	2	MM15247
Pathway	REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION	FGF2 FGF9	1.54e-03	18	46	2	MM14724
Pathway	WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS	RAMP1 NFKB1 NOS1 NOS3	1.56e-03	154	46	4	MM15974
Pathway	WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS	RAMP1 NFKB1 NOS1 NOS3	1.64e-03	156	46	4	M39475
Pathway	REACTOME_DEVELOPMENTAL_BIOLOGY	EOMES RPL24 KRT28 NTN3 NFKB1 FGF2 KMT2A FGF9 ITGA1 KRTAP13-1 PLXNB3 SEMA3E	1.69e-03	1432	46	12	M509
Pathway	REACTOME_SHC_MEDIATED_CASCADE_FGFR4	FGF2 FGF9	1.72e-03	19	46	2	MM15250
Pathway	WP_ASPIRIN_AND_MIRNAS	NFKB1 NOS3	1.72e-03	19	46	2	M48319
Pathway	REACTOME_FRS_MEDIATED_FGFR3_SIGNALING	FGF2 FGF9	1.72e-03	19	46	2	MM15245
Pathway	REACTOME_FRS_MEDIATED_FGFR3_SIGNALING	FGF2 FGF9	1.91e-03	20	46	2	M27519
Pathway	REACTOME_PI_3K_CASCADE_FGFR4	FGF2 FGF9	1.91e-03	20	46	2	M27525
Pathway	REACTOME_SHC_MEDIATED_CASCADE_FGFR4	FGF2 FGF9	1.91e-03	20	46	2	M27524
Pathway	REACTOME_PI_3K_CASCADE_FGFR4	FGF2 FGF9	1.91e-03	20	46	2	MM15251
Pathway	REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION	FGF2 FGF9	1.91e-03	20	46	2	M27062
Pathway	REACTOME_SHC_MEDIATED_CASCADE_FGFR1	FGF2 FGF9	1.91e-03	20	46	2	MM15237
Pathway	REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM	PANK4 NUDT8	1.91e-03	20	46	2	M538
Pathway	REACTOME_PI_3K_CASCADE_FGFR1	FGF2 FGF9	2.10e-03	21	46	2	M27512
Pathway	REACTOME_SHC_MEDIATED_CASCADE_FGFR1	FGF2 FGF9	2.10e-03	21	46	2	M27511
Pathway	WP_EBV_LMP1_SIGNALING	NFKB1 NFKB2	2.10e-03	21	46	2	MM15923
Pathway	WP_BURN_WOUND_HEALING	FGF2 NOS3	2.10e-03	21	46	2	MM15978
Pathway	REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS	NFKB1 NFKB2	2.10e-03	21	46	2	M26978
Pathway	REACTOME_INFLAMMASOMES	NFKB1 NFKB2	2.10e-03	21	46	2	M1072
Pathway	REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION	MARS2 NARS2	2.10e-03	21	46	2	M15096
Pathway	REACTOME_PI_3K_CASCADE_FGFR1	FGF2 FGF9	2.10e-03	21	46	2	MM15238
Pathway	REACTOME_FRS_MEDIATED_FGFR4_SIGNALING	FGF2 FGF9	2.10e-03	21	46	2	MM15248
Pathway	REACTOME_SHC_MEDIATED_CASCADE_FGFR2	FGF2 FGF9	2.10e-03	21	46	2	MM15242
Pathway	REACTOME_FRS_MEDIATED_FGFR4_SIGNALING	FGF2 FGF9	2.31e-03	22	46	2	M27522
Pathway	REACTOME_FRS_MEDIATED_FGFR1_SIGNALING	FGF2 FGF9	2.31e-03	22	46	2	MM15239
Pathway	REACTOME_PI_3K_CASCADE_FGFR2	FGF2 FGF9	2.31e-03	22	46	2	MM15240
Pathway	REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE	NOS1 NOS3	2.31e-03	22	46	2	M915
Pathway	REACTOME_PI_3K_CASCADE_FGFR2	FGF2 FGF9	2.52e-03	23	46	2	M27514
Pathway	REACTOME_FRS_MEDIATED_FGFR1_SIGNALING	FGF2 FGF9	2.52e-03	23	46	2	M27513
Pathway	WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING	NFKB1 NFKB2	2.52e-03	23	46	2	M39410
Pathway	WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS	NFKB1 NFKB2	2.52e-03	23	46	2	M39862
Pathway	WP_SILDENAFIL_TREATMENT	NOS1 NOS3	2.52e-03	23	46	2	M46455
Pathway	WP_LDL_INFLUENCE_ON_CD14_AND_TLR4	NFKB1 NFKB2	2.52e-03	23	46	2	M45556
Pathway	REACTOME_FRS_MEDIATED_FGFR2_SIGNALING	FGF2 FGF9	2.52e-03	23	46	2	MM15243
Pathway	WP_ANGIOGENESIS	FGF2 NOS3	2.75e-03	24	46	2	M39556
Pathway	WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS	NOS1 NOS3	2.75e-03	24	46	2	M39850
Pathway	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3	FGF2 FGF9	2.75e-03	24	46	2	MM15246
Pathway	REACTOME_FRS_MEDIATED_FGFR2_SIGNALING	FGF2 FGF9	2.98e-03	25	46	2	M27517
Pathway	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3	FGF2 FGF9	2.98e-03	25	46	2	M27520
Pathway	REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION	NFKB1 NFKB2	2.98e-03	25	46	2	M940
Pathway	REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION	NFKB1 NFKB2	3.22e-03	26	46	2	M29838
Pathway	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4	FGF2 FGF9	3.22e-03	26	46	2	MM15249
Pathway	WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING	CYP11B1 NFKB1 NOS3	3.33e-03	92	46	3	M39441
Pathway	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4	FGF2 FGF9	3.47e-03	27	46	2	M27523
Pathway	REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2	FGF2 FGF9	3.73e-03	28	46	2	MM15241
Pathway	WP_NEURAL_CREST_DIFFERENTIATION	NFKB1 NFKB2 FGF2	3.87e-03	97	46	3	MM15926
Pathway	KEGG_PATHWAYS_IN_CANCER	NFKB1 NFKB2 WNT8B FGF2 FGF9	3.99e-03	325	46	5	M12868
Pathway	REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING	FGF2 FGF9	4.00e-03	29	46	2	M27528
Pubmed	Nitric oxide inhibits HIV tat-induced NF-kappaB activation.	NFKB1 NFKB2 NOS3	3.63e-07	8	66	3	10393859
Pubmed	CAPS1 and CAPS2 regulate stability and recruitment of insulin granules in mouse pancreatic beta cells.	CADPS CADPS2	3.55e-06	2	66	2	18177725
Pubmed	Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors.	KMT2A GAS7	3.55e-06	2	66	2	10706619
Pubmed	Nuclear factor kappa-B mediates selective induction of neuronal nitric oxide synthase in astrocytes during low-level inflammatory stimulation with MPTP.	NFKB1 NOS1	3.55e-06	2	66	2	18508038
Pubmed	Differential roles of neuronal and endothelial nitric oxide synthases during carrageenan-induced inflammatory hyperalgesia.	NOS1 NOS3	3.55e-06	2	66	2	15350652
Pubmed	Mechanochemotransduction during cardiomyocyte contraction is mediated by localized nitric oxide signaling.	NOS1 NOS3	3.55e-06	2	66	2	24643800
Pubmed	Quantitative dissection and modeling of the NF-κB p100-p105 module reveals interdependent precursor proteolysis.	NFKB1 NFKB2	3.55e-06	2	66	2	25482563
Pubmed	Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with the development of lupus nephritis.	NOS1 NOS3	3.55e-06	2	66	2	15119548
Pubmed	Modulation of the myogenic response in renal blood flow autoregulation by NO depends on endothelial nitric oxide synthase (eNOS), but not neuronal or inducible NOS.	NOS1 NOS3	3.55e-06	2	66	2	21825026
Pubmed	Chronic NOS inhibition actuates endothelial-mesenchymal transformation.	NOS1 NOS3	3.55e-06	2	66	2	16963618
Pubmed	Structural analysis and detection of biological inositol pyrophosphates reveal that the family of VIP/diphosphoinositol pentakisphosphate kinases are 1/3-kinases.	PPIP5K1 PPIP5K2	3.55e-06	2	66	2	18981179
Pubmed	Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice.	NOS1 NOS3	3.55e-06	2	66	2	8667023
Pubmed	nNOS and eNOS modulate cGMP formation and vascular response in contracting fast-twitch skeletal muscle.	NOS1 NOS3	3.55e-06	2	66	2	11015578
Pubmed	Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.	NFKB1 NFKB2	3.55e-06	2	66	2	28368397
Pubmed	NFKB1 promoter variation implicates shear-induced NOS3 gene expression and endothelial function in prehypertensives and stage I hypertensives.	NFKB1 NOS3	3.55e-06	2	66	2	17644577
Pubmed	Renal cortical and medullary blood flow responses to L-NAME and ANG II in wild-type, nNOS null mutant, and eNOS null mutant mice.	NOS1 NOS3	3.55e-06	2	66	2	15961532
Pubmed	Contributions of endothelial and neuronal nitric oxide synthases to cerebrovascular responses to hyperoxia.	NOS1 NOS3	3.55e-06	2	66	2	14526232
Pubmed	Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption.	NFKB1 NFKB2	3.55e-06	2	66	2	12568403
Pubmed	Nitric oxide synthase polymorphisms and asthma phenotypes in Chinese children.	NOS1 NOS3	3.55e-06	2	66	2	16238787
Pubmed	Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism.	NOS1 NOS3	3.55e-06	2	66	2	24076963
Pubmed	Normal development of the ipsilateral retinocollicular pathway and its disruption in double endothelial and neuronal nitric oxide synthase gene knockout mice.	NOS1 NOS3	3.55e-06	2	66	2	11027405
Pubmed	Neuronal nitric oxide synthase plays a key role in CNS demyelination.	NOS1 NOS3	3.55e-06	2	66	2	17151270
Pubmed	Transient hypoxia stimulates mitochondrial biogenesis in brain subcortex by a neuronal nitric oxide synthase-dependent mechanism.	NOS1 NOS3	3.55e-06	2	66	2	18305236
Pubmed	Regulation of renin gene expression in kidneys of eNOS- and nNOS-deficient mice.	NOS1 NOS3	3.55e-06	2	66	2	10764216
Pubmed	Repetitive hyperbaric oxygen exposures enhance sensitivity to convulsion by upregulation of eNOS and nNOS.	NOS1 NOS3	3.55e-06	2	66	2	18342297
Pubmed	Cysteine 99 of endothelial nitric oxide synthase (NOS-III) is critical for tetrahydrobiopterin-dependent NOS-III stability and activity.	NOS1 NOS3	3.55e-06	2	66	2	7488039
Pubmed	The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration.	NOS1 NOS3	3.55e-06	2	66	2	19087148
Pubmed	Genetic analysis of NOS isoforms using nNOS and eNOS knockout animals.	NOS1 NOS3	3.55e-06	2	66	2	9932431
Pubmed	Rapid cerebral ischemic preconditioning in mice deficient in endothelial and neuronal nitric oxide synthases.	NOS1 NOS3	3.55e-06	2	66	2	12677017
Pubmed	Experience-dependent plasticity acts via GluR1 and a novel neuronal nitric oxide synthase-dependent synaptic mechanism in adult cortex.	NOS1 NOS3	3.55e-06	2	66	2	21813683
Pubmed	Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production.	NOS1 NOS3	3.55e-06	2	66	2	15044250
Pubmed	NF-kappaB to the rescue: RELs, apoptosis and cellular transformation.	NFKB1 NFKB2	3.55e-06	2	66	2	10354583
Pubmed	Cutaneous neuronal nitric oxide is specifically decreased in postural tachycardia syndrome.	NOS1 NOS3	3.55e-06	2	66	2	17660395
Pubmed	Endothelial Nitric Oxide Synthase Is Present in Dendritic Spines of Neurons in Primary Cultures.	NOS1 NOS3	3.55e-06	2	66	2	28725180
Pubmed	Reproductive function in female mice lacking the gene for endothelial nitric oxide synthase.	NOS1 NOS3	3.55e-06	2	66	2	10534440
Pubmed	Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma.	RNF123 NFKB1	3.55e-06	2	66	2	28389511
Pubmed	Analysis of nitric oxide synthase gene polymorphisms in neonatal respiratory distress syndrome among the Chinese Han population.	NOS1 NOS3	3.55e-06	2	66	2	24602444
Pubmed	Combined loss of neuronal and endothelial nitric oxide synthase causes premature mortality and age-related hypertrophic cardiac remodeling in mice.	NOS1 NOS3	3.55e-06	2	66	2	12788381
Pubmed	CAPS-1 and CAPS-2 are essential synaptic vesicle priming proteins.	CADPS CADPS2	3.55e-06	2	66	2	18022372
Pubmed	Angiotensin II response in afferent arterioles of mice lacking either the endothelial or neuronal isoform of nitric oxide synthase.	NOS1 NOS3	3.55e-06	2	66	2	17959704
Pubmed	Effects of nitric oxide synthase gene knockout on neurotransmitter release in vivo.	NOS1 NOS3	3.55e-06	2	66	2	9692709
Pubmed	Myocardial and lymphocytic expression of eNOS and nNOS before and after heart transplantation: relationship to clinical status.	NOS1 NOS3	3.55e-06	2	66	2	23770231
Pubmed	Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis.	NOS1 NOS3	3.55e-06	2	66	2	15287858
Pubmed	Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance.	NOS1 NOS3	3.55e-06	2	66	2	10905473
Pubmed	Nitric oxide synthase gene polymorphisms in children with minimal change nephrotic syndrome.	NOS1 NOS3	3.55e-06	2	66	2	19371282
Pubmed	Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism.	NFKB1 NFKB2	3.55e-06	2	66	2	18250170
Pubmed	Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms.	NOS1 NOS3	3.55e-06	2	66	2	11907582
Pubmed	Relative contribution of eNOS and nNOS to endothelium-dependent vasodilation in the mouse aorta.	NOS1 NOS3	3.55e-06	2	66	2	20624383
Pubmed	New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases.	NFKB1 NFKB2	3.55e-06	2	66	2	9895331
Pubmed	Neuronal NOS-cGMP-dependent ACh-induced relaxation in pial arterioles of endothelial NOS knockout mice.	NOS1 NOS3	3.55e-06	2	66	2	9486242
Pubmed	Refinement of the ipsilateral retinocollicular projection is disrupted in double endothelial and neuronal nitric oxide synthase gene knockout mice.	NOS1 NOS3	3.55e-06	2	66	2	10727738
Pubmed	Developmental changes in the response of murine cerebellar granule cells to nitric oxide.	NOS1 NOS3	3.55e-06	2	66	2	18406496
Pubmed	Diminished NO generation by injured endothelium and loss of macula densa nNOS may contribute to sustained acute kidney injury after ischemia-reperfusion.	NOS1 NOS3	3.55e-06	2	66	2	18971208
Pubmed	Does endothelial nitric oxide synthase gene variation play a role in the occurrence of hypertension in pregnancy?	NOS1 NOS3	3.55e-06	2	66	2	12908999
Pubmed	Role of nitric oxide synthase on brain GABA transaminase activity and GABA levels.	NOS1 NOS3	3.55e-06	2	66	2	31259693
Pubmed	Nitric oxide contributes to vascular smooth muscle relaxation in contracting fast-twitch muscles.	NOS1 NOS3	3.55e-06	2	66	2	11161004
Pubmed	CAPS-1 requires its C2, PH, MHD1 and DCV domains for dense core vesicle exocytosis in mammalian CNS neurons.	CADPS CADPS2	3.55e-06	2	66	2	28883501
Pubmed	How do nuclear factor kappa B (NF-κB)1 and NF-κB2 defects lead to the incidence of clinical and immunological manifestations of inborn errors of immunity?	NFKB1 NFKB2	3.55e-06	2	66	2	36706462
Pubmed	Neuronal and endothelial nitric oxide synthase gene knockout mice.	NOS1 NOS3	3.55e-06	2	66	2	10559836
Pubmed	A short binding site in the KPC1 ubiquitin ligase mediates processing of NF-κB1 p105 to p50: A potential for a tumor-suppressive PROTAC.	RNF123 NFKB1	3.55e-06	2	66	2	34873064
Pubmed	Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential.	FGF2 FGF9	3.55e-06	2	66	2	15780951
Pubmed	The cerebral metabolic consequences of nitric oxide synthase deficiency: glucose utilization in endothelial and neuronal nitric oxide synthase null mice.	NOS1 NOS3	3.55e-06	2	66	2	10027769
Pubmed	Priapism in a Fabry disease mouse model is associated with upregulated penile nNOS and eNOS expression.	NOS1 NOS3	3.55e-06	2	66	2	29110178
Pubmed	The Significance of the Bifunctional Kinase/Phosphatase Activities of Diphosphoinositol Pentakisphosphate Kinases (PPIP5Ks) for Coupling Inositol Pyrophosphate Cell Signaling to Cellular Phosphate Homeostasis.	PPIP5K1 PPIP5K2	3.55e-06	2	66	2	28126903
Pubmed	Carvedilol induces biased β1 adrenergic receptor-nitric oxide synthase 3-cyclic guanylyl monophosphate signalling to promote cardiac contractility.	NOS1 NOS3	3.55e-06	2	66	2	32956449
Pubmed	Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection.	NOS1 NOS3	3.55e-06	2	66	2	11904450
Pubmed	Modulation by NO of acetylcholine release in the ileum of wild-type and NOS gene knockout mice.	NOS1 NOS3	3.55e-06	2	66	2	12381527
Pubmed	Contribution of nNOS- and eNOS-derived NO to microvascular smooth muscle NO exposure.	NOS1 NOS3	3.55e-06	2	66	2	15033959
Pubmed	Liver-Resident NK Cells: The Human Factor.	EOMES ITGA1	3.55e-06	2	66	2	28318877
Pubmed	Infarct size and nitric oxide synthase in murine myocardium.	NOS1 NOS3	3.55e-06	2	66	2	10652188
Pubmed	Gastric stasis in neuronal nitric oxide synthase-deficient knockout mice.	NOS1 NOS3	3.55e-06	2	66	2	10982771
Pubmed	Two distinct secretory vesicle-priming steps in adrenal chromaffin cells.	CADPS CADPS2	3.55e-06	2	66	2	20855507
Pubmed	Related subunits of NF-kappa B map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2.	NFKB1 NFKB2	3.55e-06	2	66	2	1612589
Pubmed	Impairment of neocortical long-term potentiation in mice deficient of endothelial nitric oxide synthase.	FGF2 NOS3	3.55e-06	2	66	2	10036253
Pubmed	The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas.	NFKB1 NFKB2	3.55e-06	2	66	2	16751281
Pubmed	Regulation of brain glutamate metabolism by nitric oxide and S-nitrosylation.	NOS1 NOS3	3.55e-06	2	66	2	26152695
Pubmed	Alternatively spliced neuronal nitric oxide synthase mediates penile erection.	NOS1 NOS3	3.55e-06	2	66	2	16488973
Pubmed	The Krebs cycle and mitochondrial mass are early victims of endothelial dysfunction: proteomic approach.	NOS1 NOS3	3.55e-06	2	66	2	19095954
Pubmed	CAPS facilitates filling of the rapidly releasable pool of large dense-core vesicles.	CADPS CADPS2	3.55e-06	2	66	2	18495893
Pubmed	Neuronal nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo.	NOS1 NOS3	3.55e-06	2	66	2	18048451
Pubmed	Monitoring a nuclear factor-κB signature of drug resistance in multiple myeloma.	NFKB1 NFKB2	3.55e-06	2	66	2	21846842
Pubmed	Immunocytochemical distribution of nitric oxide synthase in the human seminal vesicle: a light and electron microscopical study.	NOS1 NOS3	3.55e-06	2	66	2	12802542
Pubmed	Oxygen seizure latency and peroxynitrite formation in mice lacking neuronal or endothelial nitric oxide synthases.	NOS1 NOS3	3.55e-06	2	66	2	12781920
Pubmed	Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS.	NOS1 NOS3	3.55e-06	2	66	2	7518615
Pubmed	Proteolytic degradation of nitric oxide synthase isoforms by calpain is modulated by the expression levels of HSP90.	NOS1 NOS3	3.55e-06	2	66	2	17970747
Pubmed	Physician-diagnosed asthma and acute chest syndrome: associations with NOS polymorphisms.	NOS1 NOS3	3.55e-06	2	66	2	17351927
Pubmed	Establishment of patterned thalamocortical connections does not require nitric oxide synthase.	NOS1 NOS3	3.55e-06	2	66	2	9786989
Pubmed	Endothelial nitric oxide synthase is predominantly involved in angiotensin II modulation of renal vascular resistance and norepinephrine release.	NOS1 NOS3	3.55e-06	2	66	2	18046021
Pubmed	Nitric oxide synthase gene polymorphisms in children with primary nocturnal enuresis: a preliminary study.	NOS1 NOS3	3.55e-06	2	66	2	17365914
Pubmed	NOS-I and -III gene variants are differentially associated with facets of suicidal behavior and aggression-related traits.	NOS1 NOS3	3.55e-06	2	66	2	17579350
Pubmed	Are myocardial eNOS and nNOS involved in the beta-adrenergic and muscarinic regulation of inotropy? A systematic investigation.	NOS1 NOS3	3.55e-06	2	66	2	16545353
Pubmed	Neuronal nitric oxide synthase in epidermis is involved in cutaneous circulatory response to mechanical stimulation.	NOS1 NOS3	3.55e-06	2	66	2	19940861
Pubmed	Displacement-encoded and manganese-enhanced cardiac MRI reveal that nNOS, not eNOS, plays a dominant role in modulating contraction and calcium influx in the mammalian heart.	NOS1 NOS3	3.55e-06	2	66	2	22058155
Pubmed	Neuronal nitric oxide synthase (NOS-I) knockout increases the survival rate of neural cells in the hippocampus independently of BDNF.	NOS1 NOS3	3.55e-06	2	66	2	17459722
Pubmed	NF-kappa B binds to the immunoglobulin S gamma 3 region in vivo during class switch recombination.	NFKB1 NFKB2	3.55e-06	2	66	2	17109470
Pubmed	Requirement for NF-kappaB in osteoclast and B-cell development.	NFKB1 NFKB2	3.55e-06	2	66	2	9407039
Pubmed	Structures of human constitutive nitric oxide synthases.	NOS1 NOS3	3.55e-06	2	66	2	25286850
Pubmed	Protective role of peroxisome proliferator-activated receptor-β/δ against pulmonary oxygen toxicity mediated through changes in NOS expression levels.	NOS1 NOS3	3.55e-06	2	66	2	24624894
Pubmed	Characterization of a nitric oxide synthase from the plant kingdom: NO generation from the green alga Ostreococcus tauri is light irradiance and growth phase dependent.	NOS1 NOS3	3.55e-06	2	66	2	21119059
Pubmed	Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase.	NOS1 NOS3	3.55e-06	2	66	2	8978606
Cytoband	10q24	NFKB2 WNT8B	1.17e-03	35	66	2	10q24
GeneFamily	Ankyrin repeat domain containing\|NF-kappa B complex subunits	NFKB1 NFKB2	7.46e-05	5	50	2	1254
GeneFamily	Aminoacyl tRNA synthetases, Class II	NARS1 NARS2	1.24e-03	19	50	2	132
GeneFamily	Zinc fingers CCHC-type\|RNA binding motif containing	RTL3 ZCCHC3	2.16e-03	25	50	2	74
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#1	RAMP1 GPATCH3 GAS7 EFCC1 NUDT8 KIR3DL2 GPR179	2.69e-05	291	64	7	Facebase_RNAseq_e10.5_Medial Nasal Eminence_500_K1
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SASH1 ADAMTS20 EFCC1 ITGA1 PKHD1L1	7.30e-06	181	66	5	e898ecb8d8f2eb2204225b7b0d665cadcd241139
ToppCell	COVID-19-lung-Vein_EC\|lung / Disease (COVID-19 only), tissue and cell type	SASH1 CADPS2 PKHD1L1 NOS1 NOS3	8.78e-06	188	66	5	d582b76fc2faac526c9bf97503041129e1a6a211
ToppCell	droplet-Heart-HEART-1m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT28 ADAMTS20 GAS7 PLXNB3 DNAH11	9.01e-06	189	66	5	a618a1ddf5097a010c6c2c7341f3a0bd46a29c02
ToppCell	droplet-Heart-HEART-1m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT28 ADAMTS20 GAS7 PLXNB3 DNAH11	9.01e-06	189	66	5	4e61f9cd1c06bddb47ebf98affc0f97770e26e8c
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	SASH1 ITGA1 CADPS2 PKHD1L1 NOS3	9.01e-06	189	66	5	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SASH1 CADPS ADAMTS20 NOS1 ALK	1.02e-05	194	66	5	e5990880961d2469759ce4b3b20ae93ace3ebd1f
ToppCell	COVID-19-Lymphoid-CD8_T_cells\|Lymphoid / Condition, Lineage and Cell class	EOMES APMAP GAS7 ITGA1 KIR3DL2	1.05e-05	195	66	5	d4c70a462b98963e78f4e2659574bc350f8ffe1a
ToppCell	normal_Lymph_Node-T/NK_cells-NK\|normal_Lymph_Node / Location, Cell class and cell subclass	EOMES RAMP1 APMAP GAS7 KIR3DL2	1.07e-05	196	66	5	00ab4a1547752d419aa720b39b94a4ab2ede963a
ToppCell	normal_Lymph_Node-T/NK_cells-NK\|T/NK_cells / Location, Cell class and cell subclass	EOMES RAMP1 APMAP GAS7 KIR3DL2	1.13e-05	198	66	5	75e94298bf03d755fef46df685437d0d29fdbca9
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SASH1 ADAMTS20 ITGA1 NOS1 ALK	1.18e-05	200	66	5	107854f4855fc99c9f7e737eb246f0d868e6c5fd
ToppCell	facs-Heart-RV-24m-Myeloid-macrophage\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAMP1 MYO1A FGF9 DMWD	4.84e-05	135	66	4	99e7ac9b1139fe4ff036f6f048a8f1cc514c1fb9
ToppCell	facs-Heart-RV-24m-Myeloid-macrophage\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAMP1 MYO1A FGF9 DMWD	4.84e-05	135	66	4	1fe684ed5913ae757ad6befbbe12d1bee481dd12
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FGF9 NOS1 ALK SEMA3E	7.67e-05	152	66	4	fed80b467ec9e30c7f98bed6cc4f8c583b715e9e
ToppCell	ICU-SEP-Lymphocyte-T_NK-gdT\|ICU-SEP / Disease, Lineage and Cell Type	EOMES APMAP KIR3DL2 NOS1	9.35e-05	160	66	4	0a14b1fed54a09c0caf263662b5bd426466c7189
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Lamp5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FGF9 NOS1 ALK SEMA3E	1.03e-04	164	66	4	08819970174a3eb4eee8e1e675075828665b845e
ToppCell	10x5'-GI_small-bowel-Lymphocytic_NK-NK_CD56bright_CD16-\|GI_small-bowel / Manually curated celltypes from each tissue	EOMES RAMP1 GJD3 GAS7	1.03e-04	164	66	4	36e64e4f717dd59b352c20ff9742ca1e232342bb
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	EOMES RAMP1 RTL3 APMAP	1.08e-04	166	66	4	61e4b2d2db093e64f7354b534aa8571803a3bd44
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CADPS NFKB1 NFKB2 C1QTNF4	1.18e-04	170	66	4	be2a34c70665d8d11332b1a70eda03d77cb7f7dd
ToppCell	NS-critical-LOC-Lymphoid-NK\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	EOMES APMAP ITGA1 KIR3DL2	1.21e-04	171	66	4	adda76991d9b150bb8ccf3989b7cbbf41843cf0b
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES RAMP1 APMAP KIR3DL2	1.24e-04	172	66	4	86f52f486d67217fc1b8443ab362c975df2974a4
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES RAMP1 APMAP KIR3DL2	1.24e-04	172	66	4	fb2df8fea6df5947165f13978f1d1006d15b60fd
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES RAMP1 APMAP KIR3DL2	1.24e-04	172	66	4	e38ebb216e4ddcd008148fcbaf709b4f3c83706a
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES RAMP1 APMAP KIR3DL2	1.24e-04	172	66	4	e3a8891694343b6b01e80a200ae338d24797e417
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES APMAP EFCC1 KIR3DL2	1.32e-04	175	66	4	8fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4
ToppCell	metastatic_Brain-Myeloid_cells-Activated_DCs\|Myeloid_cells / Location, Cell class and cell subclass	CD1B ZDHHC18 PANK4 DNAH11	1.35e-04	176	66	4	9c1f255de3082b3da4bef2a9bdff710cfd48261f
ToppCell	facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GJD3 EFCC1 PKHD1L1 NOS3	1.35e-04	176	66	4	460cb302c5b3d609c65b924e1d4e8ea057a68485
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SASH1 EFCC1 PKHD1L1 PLXNB3	1.38e-04	177	66	4	b1775e05c28883a15c56628028770bc59d3233fb
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FGF9 EFCC1 GPR179 SEMA3E	1.44e-04	179	66	4	7c8a2fa1326c73dc9e774df645b572864fd97133
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EOMES RAMP1 APMAP ALK	1.50e-04	181	66	4	9c4f9abb9335da2b07644bca8faff1baa1bb9f5b
ToppCell	3'_v3-Lung-Myeloid_Dendritic-migDC\|Lung / Manually curated celltypes from each tissue	CD1B RAMP1 NFKB1 NOS1	1.54e-04	182	66	4	cd6e3a9f4eb4fe73b28da61d1d35c64fd9ffa892
ToppCell	Globus_pallidus-Neuronal-Inhibitory\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	CADPS HAPLN4 FGF9 ALK	1.54e-04	182	66	4	04ccfa951eaa31fed6d140edb6c702d49363c5fa
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_KLHL14\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SASH1 ADAMTS20 ITGA1 ALK	1.57e-04	183	66	4	439b1d1373b7cc73d65f3b59037a6def7cf8f4ba
ToppCell	Control-Endothelial_cells-Pulmonary_venous_endothelial_cells\|Control / group, cell type (main and fine annotations)	SASH1 PKHD1L1 NOS1 NOS3	1.57e-04	183	66	4	46be9f96755c7b65aeac061d95d15abeb6466034
ToppCell	droplet-Limb_Muscle-nan-3m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS20 GAS7 PLXNB3 SEMA3E	1.60e-04	184	66	4	da8d6e7944eb35e6cbea2feb7cbc2894787d723f
ToppCell	COVID-19-Neuronal_cells-Neuronal_cells\|COVID-19 / group, cell type (main and fine annotations)	SASH1 EFCC1 ITGA1 PKHD1L1	1.63e-04	185	66	4	4a095829992b39856a73bdfac03ee68b9aa0d3b8
ToppCell	COVID-19-Neuronal_cells\|COVID-19 / group, cell type (main and fine annotations)	SASH1 EFCC1 ITGA1 PKHD1L1	1.63e-04	185	66	4	36ce23893915f5c380cca39b2c33a516edf31c3a
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SASH1 ADAMTS20 EFCC1 PKHD1L1	1.67e-04	186	66	4	20340a5b5cc7f07386498a4ef937d6fbc9e347c4
ToppCell	normal_Lung-Myeloid_cells-Activated_DCs\|Myeloid_cells / Location, Cell class and cell subclass	CD1B RAMP1 FGF9 NOS1	1.67e-04	186	66	4	00ad1239b952119b3fd2e6af8f034cba3488f9c1
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	SASH1 CADPS2 PKHD1L1 NOS3	1.70e-04	187	66	4	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	SASH1 PKHD1L1 NOS1 NOS3	1.70e-04	187	66	4	2d20193a6cacdfa4877457c97b0077408942186c
ToppCell	droplet-Limb_Muscle-nan-24m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS20 GAS7 PLXNB3 SEMA3E	1.70e-04	187	66	4	a0bd2b0ec9e73521c245037b1dd51ff8cf24cbf5
ToppCell	droplet-Limb_Muscle-nan-24m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS20 GAS7 PLXNB3 SEMA3E	1.70e-04	187	66	4	f2af79a20438108c814a73f9e24cd986d537237f
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EOMES CADPS HAPLN4 C1QTNF4	1.74e-04	188	66	4	1efbc99bcd6542e5d9fa91edb7c4295167914786
ToppCell	NS-critical-d_16-33-Lymphoid-CTL\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	EOMES APMAP ITGA1 KIR3DL2	1.77e-04	189	66	4	8a02c40bfc92cee37c4dee7c7bf98ab826f64a14
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)\|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	EOMES ZDHHC18 DGAT2 NFKB2	1.77e-04	189	66	4	0fe8901e10c619c93b7788792da1706a32102c6e
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	SASH1 ITGA1 CADPS2 PKHD1L1	1.77e-04	189	66	4	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HAPLN4 C1QTNF4 CADPS2 NOS1	1.77e-04	189	66	4	f57200c93d39c9bce1adba0a6a1c178c028dd86b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SASH1 GAS7 EFCC1 PKHD1L1	1.81e-04	190	66	4	876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD1B RAMP1 NFKB1 NFKB2	1.81e-04	190	66	4	2ff4b50b864a35f22c558d7d585cd2b54612b50c
ToppCell	COVID-19-lung-Vein_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SASH1 CADPS2 PKHD1L1 NOS3	1.81e-04	190	66	4	1caeaef78326734c1e31a0c4739190d5c5a77b9e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RAMP1 CADPS ITGA1 SEMA3E	1.81e-04	190	66	4	562ee3b025c29edf07b8b344323edb49d82f1c7e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RAMP1 CADPS ITGA1 SEMA3E	1.81e-04	190	66	4	f5fb989afabb49d64d91324570cd8c80a4b9e67d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SASH1 GAS7 EFCC1 PKHD1L1	1.81e-04	190	66	4	be9f36127028f52ca5fc1b32ba15a6c26aad69ac
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD1B RAMP1 NFKB1 NFKB2	1.81e-04	190	66	4	5175bf022d55a52988014abe7cece326a8406a38
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SASH1 GAS7 EFCC1 PKHD1L1	1.81e-04	190	66	4	09a8855901c3c9332dbaab3e40166485b696d0f1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES RAMP1 APMAP KIR3DL2	1.81e-04	190	66	4	600b9674197f743dea1d19d3df0fc993b6e6aa25
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic-dendritic_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD1B RAMP1 NFKB1 NFKB2	1.81e-04	190	66	4	29e60b9b1c86b44550619c01306b8b1bb2e340dc
ToppCell	3'_v3-bone_marrow\|World / Manually curated celltypes from each tissue	RAMP1 APMAP GAS7 EMP3	1.85e-04	191	66	4	7b759831f1b1c8575c31f67d0d9eb11c6a833cf3
ToppCell	IPF-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	RAMP1 APMAP GAS7 KIR3DL2	1.85e-04	191	66	4	f2ddc0962007d7a4e78fbd916ebb62fc557d480a
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	ITGA1 CADPS2 PKHD1L1 NOS3	1.85e-04	191	66	4	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SASH1 ADAMTS20 ITGA1 ALK	1.85e-04	191	66	4	9c0ee270209b02043393416ecc9a81ddedfbb8b6
ToppCell	critical-Lymphoid-CTL\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	EOMES KMT2A ITGA1 KIR3DL2	1.88e-04	192	66	4	8c83050c1578d43ca0398ff920f30ea63f092a83
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_10\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CD1B RAMP1 NFKB1 NFKB2	1.88e-04	192	66	4	2c69f3f388b69fb1c1968c923cdbab90658883dd
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GPR20 CADPS ITGA1 DNAH11	1.88e-04	192	66	4	24e2f15f5767a97eb3b389922bcfd7b13805e1ce
ToppCell	normal_Pleural_Fluid-T/NK_cells-NK\|normal_Pleural_Fluid / Location, Cell class and cell subclass	EOMES RAMP1 APMAP KIR3DL2	1.88e-04	192	66	4	59dd4f5ae9f1cca78adf60b71661092ef09e6641
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_10\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CD1B RAMP1 NFKB1 NFKB2	1.88e-04	192	66	4	d5a7b546ebfb2e757dd9c64cb1b651f6ed0e0fc7
ToppCell	wk_08-11-Epithelial-PNS-KCNIP4+_neuron\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	RAMP1 NOS1 ALK GPR179	1.88e-04	192	66	4	53642c88891f4e4e14b1740c5ced759b7d8b3572
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES RAMP1 APMAP KIR3DL2	1.88e-04	192	66	4	c5f77c2103841505d13e09173549811312ef2f01
ToppCell	control-NK\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	EOMES RAMP1 APMAP KIR3DL2	1.88e-04	192	66	4	cec6ab5793953072e6b0fee370551224947dd877
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	ITGA1 CADPS2 PKHD1L1 NOS3	1.88e-04	192	66	4	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES RAMP1 APMAP KIR3DL2	1.88e-04	192	66	4	e981162f387a31111c0ae8355dbe9db5785c4838
ToppCell	NS-critical-d_07-13-Lymphoid-CTL\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	EOMES KMT2A ITGA1 KIR3DL2	1.88e-04	192	66	4	e7e5ba94ee8fd3c04bb4c358c86d0227c563e9dc
ToppCell	facs-Brain_Non-Myeloid-Striatum\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DGAT2 GAS7 EFCC1 DMWD	1.92e-04	193	66	4	d8ccfb780a75bdf9141f41fb29a076958601ebb4
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	SASH1 ITGA1 CADPS2 PKHD1L1	1.92e-04	193	66	4	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SASH1 ADAMTS20 ITGA1 NOS1	1.92e-04	193	66	4	010717ca052b6c8a525a43aaeffddea0d1113e63
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES RAMP1 APMAP KIR3DL2	1.92e-04	193	66	4	54604c2c5dce2ff6f3ec7ca82b595b09b8cdafe8
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SASH1 PKHD1L1 NOS1 NOS3	1.92e-04	193	66	4	9ba688b35a9ead5d04691b3f3f15484f02dbbd0d
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	SASH1 ITGA1 CADPS2 PKHD1L1	1.92e-04	193	66	4	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	Int-URO-Lymphocyte-T_NK-NK\|Int-URO / Disease, Lineage and Cell Type	EOMES RAMP1 APMAP KIR3DL2	1.92e-04	193	66	4	5c7942f630fc69374df34ee3602ad973b6ced17a
ToppCell	ICU-SEP-Lymphocyte-T_NK-NK\|ICU-SEP / Disease, Lineage and Cell Type	EOMES RAMP1 APMAP KIR3DL2	1.92e-04	193	66	4	f110f86db305e41639087f5b1a2dff103c07adf0
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SASH1 ITGA1 NOS1 ALK	1.92e-04	193	66	4	5581a5ebcd21a2a8062ccfb917f088ec67a10a9c
ToppCell	NS-moderate-d_16-33-Lymphoid-CTL\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	EOMES KMT2A ITGA1 EMP3	1.96e-04	194	66	4	6b2bb3dd11fd53fa9ab4d66c18b0714f96f99288
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_5\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CD1B RAMP1 NFKB1 NFKB2	1.96e-04	194	66	4	36f8ae4f2b3bf802f6ff0e9fc79e7f170f96ae8b
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	SASH1 CADPS2 PKHD1L1 NOS3	1.96e-04	194	66	4	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	Control-Myeloid-Migratory_DC\|Control / Condition, Lineage and Cell class	CD1B RAMP1 NFKB1 NFKB2	1.96e-04	194	66	4	374076e60dcee83eb1814aa6b55b77668909f40b
ToppCell	ICU-NoSEP-Lymphocyte-T_NK-NK\|ICU-NoSEP / Disease, Lineage and Cell Type	EOMES RAMP1 APMAP KIR3DL2	1.96e-04	194	66	4	090edfc884655e5ab38b027c6e1a5aa809ebb19d
ToppCell	Leuk-UTI-Lymphocyte-T_NK-NK\|Leuk-UTI / Disease, Lineage and Cell Type	EOMES RAMP1 APMAP KIR3DL2	1.96e-04	194	66	4	36afc4e48d267be3b8aa1e33fad043bcd54c6bc5
ToppCell	distal-1-Hematologic-Myeloid_Dendritic_Type_1\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD1B ZDHHC18 RAMP1 NFKB1	1.96e-04	194	66	4	85a4be291c25ad1fb14199b87d822cf47d748fc0
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES RAMP1 APMAP KIR3DL2	1.96e-04	194	66	4	52e09b14159b609af00264a8f38accf37ba8f464
ToppCell	10x5'-Lung-Lymphocytic_NK-NK_CD16\|Lung / Manually curated celltypes from each tissue	EOMES RAMP1 APMAP KIR3DL2	2.00e-04	195	66	4	e91e7f89163c615b706f3297b641b1e4c966f5e6
ToppCell	BLOOD--(1)_T_cell-(1)_EM_CTLs\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	EOMES APMAP EMP3 KIR3DL2	2.00e-04	195	66	4	7df67ad5c62235474ee56ea07a957253d45f066b
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_NK\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EOMES RAMP1 APMAP KIR3DL2	2.00e-04	195	66	4	ed41e709523cc3b86b1090d4fc0938ed47cb1fc9
ToppCell	Control-Myeloid-Migratory_DC\|Myeloid / Condition, Lineage and Cell class	CD1B RAMP1 NFKB1 NFKB2	2.00e-04	195	66	4	9f1ad04abc6a6c5e093ea24b60732871b1fad5a4
ToppCell	T_cells-GZMK+_T_cells\|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	EOMES APMAP GAS7 ITGA1	2.00e-04	195	66	4	003ea7ddec6c1c98d2f6470bb51ebd97450eb936
ToppCell	3'_v3-blood-Lymphocytic_NK\|blood / Manually curated celltypes from each tissue	RAMP1 APMAP NFKB1 NFKB2	2.00e-04	195	66	4	731a454e45c7b610e0140312bcabaea711dcc766
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES RAMP1 APMAP KIR3DL2	2.00e-04	195	66	4	98b02beafe1d418442e41f85cbf0c7b194fe5957
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EOMES RAMP1 APMAP KIR3DL2	2.00e-04	195	66	4	acc603dc94ac6518adb0dffb43305b380ec75b52
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES RAMP1 APMAP KIR3DL2	2.00e-04	195	66	4	9ecae6c26a0d0607d101ccf1c38f0b23c5a256a8
ToppCell	10x5'-Lung-Lymphocytic_NK\|Lung / Manually curated celltypes from each tissue	EOMES RAMP1 APMAP KIR3DL2	2.00e-04	195	66	4	a5a10ef9254c266316e5591bec19e159cc3caead
ToppCell	normal-na-Lymphocytic_NK\|normal / PBMC cell types (v2) per disease, treatment status, and sex	EOMES RAMP1 APMAP KIR3DL2	2.00e-04	195	66	4	cebe79c42af5910353ba9ad7d0edb01982f772a3
Drug	ramiprilat	THOP1 NFKB1 NFKB2 NOS1 NOS3	5.46e-07	55	66	5	CID005464096
Drug	triflusal	NFKB1 NFKB2 NOS1 NOS3	7.78e-07	25	66	4	CID000009458
Drug	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	NOS1 NOS3	8.28e-06	2	66	2	DB01821
Drug	S-Ethyl-N-Phenyl-Isothiourea	NOS1 NOS3	8.28e-06	2	66	2	DB03707
Drug	L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide	NOS1 NOS3	8.28e-06	2	66	2	DB02077
Drug	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	NOS1 NOS3	8.28e-06	2	66	2	DB02027
Drug	N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE	NOS1 NOS3	8.28e-06	2	66	2	DB08018
Drug	N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine	NOS1 NOS3	8.28e-06	2	66	2	DB08019
Drug	Nitroarginine	NOS1 NOS3	8.28e-06	2	66	2	DB04223
Drug	S-methylisothiourea	FGF2 NOS1 NOS3	1.54e-05	17	66	3	CID000005142
Drug	ASA404	NFKB1 NFKB2 NOS1 NOS3	1.69e-05	53	66	4	CID000123964
Drug	angiotensin	THOP1 CYP11B1 NFKB1 NFKB2 FGF2 NOS1 NOS3	1.73e-05	282	66	7	CID003083715
Drug	N-(3-(Aminomethyl)Benzyl)Acetamidine	NOS1 NOS3	2.48e-05	3	66	2	DB02044
Drug	3-Bromo-7-Nitroindazole	NOS1 NOS3	2.48e-05	3	66	2	DB01997
Drug	Selara	NFKB1 NFKB2 FGF2 NOS1 NOS3	3.15e-05	125	66	5	CID000150310
Drug	phenytoin	EOMES NFKB1 NFKB2 DMWD NOS1 NOS3	4.15e-05	219	66	6	CID000001775
Drug	Tiron	EOMES NFKB1 NFKB2 NOS3	4.83e-05	69	66	4	CID000009001
Drug	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	NOS1 NOS3	4.95e-05	4	66	2	DB02692
Drug	AC1L9HIO	NOS1 NOS3	4.95e-05	4	66	2	CID000445158
Drug	N-Omega-Hydroxy-L-Arginine	NOS1 NOS3	4.95e-05	4	66	2	DB03144
Drug	panepoxydone	NFKB1 NFKB2 NOS3	5.11e-05	25	66	3	CID000161704
Drug	AC1O3R20	CYP11B1 NFKB1 NFKB2	7.24e-05	28	66	3	CID006335051
Drug	S-nitrosoacetylcysteine	NFKB1 NOS1 NOS3	8.05e-05	29	66	3	CID000122058
Drug	NSC294601	NFKB1 NFKB2	8.23e-05	5	66	2	CID000325606
Drug	AC1MVXUL	NFKB1 NFKB2	8.23e-05	5	66	2	CID003715266
Drug	AC1MNA05	NFKB1 NFKB2 GAS7	9.87e-05	31	66	3	CID003274883
Drug	goniothalamin	NFKB1 NOS1 NOS3	1.09e-04	32	66	3	ctd:C103280
Drug	L-Asparagine	NARS1 NARS2	1.23e-04	6	66	2	DB00174
Drug	NapNa	NOS1 NOS3	1.23e-04	6	66	2	CID000128726
Drug	N-nitroso-L-arginine	NOS1 NOS3	1.23e-04	6	66	2	CID000127762
Drug	1-hexacosanol	NOS1 NOS3	1.23e-04	6	66	2	ctd:C051942
Drug	AC1L1EDT	FGF2 NOS1 NOS3	1.31e-04	34	66	3	CID000002751
Drug	N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide	CYP11B1 NFKB1 FGF2 NOS1 NOS3	1.47e-04	173	66	5	ctd:C063509
Drug	trinitrobenzene	NFKB1 NFKB2 NOS1 NOS3	1.49e-04	92	66	4	CID000007434
Drug	NSC-6354	NFKB1 NFKB2 NOS1 NOS3	1.49e-04	92	66	4	CID000221534
Drug	AC1NLRUC	NOS1 NOS3	1.72e-04	7	66	2	CID004988604
Drug	Cortodoxone	CYP11B1 NFKB1	1.72e-04	7	66	2	ctd:D003350
Drug	daunorubicin semiquinone	NFKB1 NFKB2 EMP3 DMWD NOS1 NOS3	1.77e-04	285	66	6	CID000002958
Drug	diethyldithiocarbamate	NFKB1 NFKB2 NOS1 NOS3	2.13e-04	101	66	4	CID000008987
Drug	5H-purin-2-amine	NFKB1 NFKB2 KIR3DL2 NOS3	2.21e-04	102	66	4	CID000409844
Drug	udenafil	NOS1 NOS3	2.29e-04	8	66	2	ctd:C419664
Drug	4a-d	NARS1 NARS2	2.29e-04	8	66	2	CID006852126
Drug	Z-Ile-Glu(O-t-butyl)-Ala-Leucinal	NFKB1 NFKB2 FGF2	2.29e-04	41	66	3	CID009960660
Drug	calphostin C	NFKB1 FGF2 NOS3	2.29e-04	41	66	3	ctd:C058819
Drug	U0126	SPHK2 DGAT2 NFKB1 NFKB2 FGF2 NOS1 NOS3	2.43e-04	430	66	7	CID000005637
Drug	alprazolam	EOMES CYP11B1 NFKB1 NFKB2 CYP26C1	2.44e-04	193	66	5	CID000002118
Disease	Intestinal Perforation	NOS1 NOS3	1.30e-05	3	62	2	C0021845
Disease	Cleft upper lip	FGF2 FGF9 NOS3	7.65e-05	39	62	3	C0008924
Disease	Cleft palate, isolated	FGF2 FGF9 NOS3	9.57e-05	42	62	3	C1837218
Disease	Carcinoma, Granular Cell	NFKB1 KMT2A FGF9 NOS3	1.06e-04	116	62	4	C0205644
Disease	Adenocarcinoma, Tubular	NFKB1 KMT2A FGF9 NOS3	1.06e-04	116	62	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	NFKB1 KMT2A FGF9 NOS3	1.06e-04	116	62	4	C0205642
Disease	Carcinoma, Cribriform	NFKB1 KMT2A FGF9 NOS3	1.06e-04	116	62	4	C0205643
Disease	Adenocarcinoma, Basal Cell	NFKB1 KMT2A FGF9 NOS3	1.06e-04	116	62	4	C0205641
Disease	Adenocarcinoma	NFKB1 KMT2A FGF9 NOS3	1.06e-04	116	62	4	C0001418
Disease	diabetic retinopathy (biomarker_via_orthology)	FGF2 NOS1 NOS3	1.18e-04	45	62	3	DOID:8947 (biomarker_via_orthology)
Disease	low density lipoprotein cholesterol measurement, phospholipid measurement	HAPLN4 ITGA1 DMWD DNAH11	1.21e-04	120	62	4	EFO_0004611, EFO_0004639
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	NFKB1 NFKB2	1.55e-04	9	62	2	DOID:0050340 (implicated_via_orthology)
Disease	Immunoglobulin Deficiency, Late-Onset	NFKB1 NFKB2	2.36e-04	11	62	2	C2936665
Disease	Acquired Hypogammaglobulinemia	NFKB1 NFKB2	2.36e-04	11	62	2	C2936664
Disease	chronic kidney disease, Proteinuria	KMT2A GAS7	2.36e-04	11	62	2	EFO_0003884, HP_0000093
Disease	Common variable immunodeficiency	NFKB1 NFKB2	3.34e-04	13	62	2	cv:C0009447
Disease	cardiomyopathy (biomarker_via_orthology)	NOS1 NOS3	3.34e-04	13	62	2	DOID:0050700 (biomarker_via_orthology)
Disease	methylcobalamin deficiency type cblE, response to antineoplastic agent	KMT2A GAS7	3.34e-04	13	62	2	GO_0097327, MONDO_0009354
Disease	transient cerebral ischemia (implicated_via_orthology)	KMT2A NOS1 NOS3	3.36e-04	64	62	3	DOID:224 (implicated_via_orthology)
Disease	Depressive disorder	RNF123 FGF2 NOS1 ALK NOS3	3.57e-04	289	62	5	C0011581
Disease	cardiovascular disease	ZDHHC18 FGF9 C1QTNF4 CADPS2 NOS3 REXO1	3.95e-04	457	62	6	EFO_0000319
Disease	Common Variable Immunodeficiency	NFKB1 NFKB2	4.48e-04	15	62	2	C0009447
Disease	teratocarcinoma-derived growth factor 1 measurement	KMT2A GAS7	5.11e-04	16	62	2	EFO_0008297
Disease	Astrocytosis	FGF2 ITGA1	5.79e-04	17	62	2	C3887640
Disease	Gliosis	FGF2 ITGA1	5.79e-04	17	62	2	C0017639
Disease	Cleft Palate	FGF2 FGF9 NOS3	6.71e-04	81	62	3	C0008925
Disease	portal hypertension (implicated_via_orthology)	NOS1 NOS3	7.26e-04	19	62	2	DOID:10762 (implicated_via_orthology)
Disease	C-reactive protein measurement	ZDHHC18 POP5 APMAP NFKB1 CYP26C1 HAPLN4 C1QTNF4 ITGA1 DNAH11	8.91e-04	1206	62	9	EFO_0004458
Disease	impotence (biomarker_via_orthology)	NOS1 NOS3	9.77e-04	22	62	2	DOID:1875 (biomarker_via_orthology)
Disease	Bronchiectasis	NFKB2 DNAH11	9.77e-04	22	62	2	C0006267
Disease	hemoglobin change measurement	KMT2A GAS7	9.77e-04	22	62	2	EFO_0600027
Disease	S-6-hydroxywarfarin measurement	RAMP1 ADAMTS20 KMT2A GAS7 SEMA3E	1.06e-03	368	62	5	EFO_0803326
Disease	sensory peripheral neuropathy, remission	KMT2A GAS7	1.07e-03	23	62	2	EFO_0009785, MONDO_0002321
Disease	neurotic disorder	FAM120A NOS1 SEMA3E	1.27e-03	101	62	3	EFO_0004257
Disease	hypertension (biomarker_via_orthology)	CYP11B1 FGF2 NOS1 NOS3	1.34e-03	227	62	4	DOID:10763 (biomarker_via_orthology)
Disease	Antiglaucoma preparations and miotics use measurement	KMT2A GAS7	1.37e-03	26	62	2	EFO_0009944
Disease	lissencephaly (implicated_via_orthology)	NOS1 NOS3	1.47e-03	27	62	2	DOID:0050453 (implicated_via_orthology)
Disease	cystic fibrosis (is_implicated_in)	NOS1 NOS3	1.47e-03	27	62	2	DOID:1485 (is_implicated_in)
Disease	congestive heart failure (biomarker_via_orthology)	CYP11B1 NOS1 NOS3	1.50e-03	107	62	3	DOID:6000 (biomarker_via_orthology)
Disease	chronic kidney disease (biomarker_via_orthology)	DGAT2 NOS3	1.59e-03	28	62	2	DOID:784 (biomarker_via_orthology)
Disease	cerebral white matter volume change measurement, age at assessment	KMT2A GAS7	1.59e-03	28	62	2	EFO_0008007, EFO_0021499
Disease	leiomyoma (is_marker_for)	FGF2 NOS3	1.59e-03	28	62	2	DOID:127 (is_marker_for)
Disease	interleukin-8 measurement	KMT2A GAS7	1.94e-03	31	62	2	EFO_0004811
Disease	fatty liver disease (implicated_via_orthology)	DGAT2 NFKB1	1.94e-03	31	62	2	DOID:9452 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
PGSGFRAHVYLCNRP	EOMES	261	O95936
ARGCLRCAFPHVLGY	GPR20	116	Q99678
LYCRTGFHLEIFPNG	FGF9	66	P31371
AAAGVFRCRLPGAYF	C1QTNF4	216	Q9BXJ3
YFHACVAGRLRFGPQ	DNAH11	4086	Q96DT5
PRRGIIFYHGGATVF	AADACL4	111	Q5VUY2
GHLYLGSFRSPFLCR	APMAP	396	Q9HDC9
GPGRLQLVCHVSGFY	CD1B	216	P29016
GRELYFYPGCCRRGS	DMWD	131	Q09019
HARLCGYFGTRAGPR	EFCC1	146	Q9HA90
AGPSDLRHCFYRGQV	ADAMTS20	121	P59510
VHGRYFRSCPISGRA	RAMP1	96	O60894
THFCRGGHFRYTLPV	NUDT8	156	Q8WV74
THGGTYRCFGSFRAL	KIR3DL2	286	P43630
HFRYCFPFGRPEGAL	CADPS	796	Q9ULU8
YPDCGGGRLDSHRAF	OGFOD2	206	Q6N063
GPGSCRGLDHDYSRY	KRT28	126	Q7Z3Y7
VLGRYLCRCRPGFYG	GPR179	311	Q6PRD1
RRAGYAHRQGYGPFL	MYO1A	621	Q9UBC5
FREERGGGFLCFHYR	GPATCH3	36	Q96I76
GGGFLCFHYRHRPER	GPATCH3	41	Q96I76
YAERAFFPGHGGCPL	PLXNB3	1336	Q9ULL4
PYRAFRVAAASGHCG	FAM120A	906	Q9NZB2
GFLACGPLYAYRCGH	ITGA1	126	P56199
FLGSFCRYHLTEPGL	SMPD4	771	Q9NXE4
VFGLGSRAYPHFCAF	NOS1	886	P29475
GLGSRAYPHFCAFAR	NOS3	651	P29474
LDRVYFGGFFIRGHP	PANK4	316	Q9NVE7
PLGFFSSHCDLDYGR	NTN3	146	O00634
GHRYPCFFNTLHVGG	POP5	91	Q969H6
IRGSGRNFYHVPFGF	CYP11B1	431	P15538
HFRYCFPFGRPEGAL	CADPS2	761	Q86UW7
RGASSRFHYIPFGGG	CYP26C1	441	Q6V0L0
RFHYIPFGGGARSCL	CYP26C1	446	Q6V0L0
LLYGFRVAPHFACAG	GJD3	156	Q8N144
YCKNGGFFLRIHPDG	FGF2	166	P09038
VGVYRSPIHGRGLFC	KMT2A	3831	Q03164
ALGPQHRAFGSYRGR	HAPLN4	101	Q86UW8
GYGVGFCRPTYLASR	KRTAP13-1	141	Q8IUC0
LEKHPRGGSFGYCFA	EMP3	126	P54852
FGRCQLAGYGFCHVP	B9D2	86	Q9BPU9
YIGFAPCIFHGRGLF	DGAT2	306	Q96PD7
GEFRFRHGYCKGNPR	RIOK1	226	Q9BRS2
KGRLCLYCGYPGHFA	RTL3	441	Q8N8U3
RPYCHFRHRGARGSG	REXO1	26	Q8N1G1
CPHGGYGLGLERFLT	NARS1	511	O43776
YLDLRRFGSVPHGGF	NARS2	431	Q96I59
CRTLYPFSGERHGQG	GAS7	6	O60861
LFRLRHFPCGNVNYG	ALK	1571	Q9UM73
YFCSRAERPRGGAAH	WNT8B	331	Q93098
RHLPGAFFLGAERGY	ZCCHC3	311	Q9NUD5
CSFSGYKIYPGHGRR	RPL24	6	P83731
LHGEFGSYPARGPRF	SPHK2	51	Q9NRA0
GCGFGYRYTRLPHLL	RNF123	976	Q5XPI4
YRGPFCGRARVHTDF	SASH1	551	O94885
YIRGCAFHHGFSPAI	PKHD1L1	3336	Q86WI1
RFYGHPCPFEGRRLG	MARS2	556	Q96GW9
PGGGLHRCLACARYF	ZNF593	56	O00488
RGAYGRPGSDFCHGT	ZNF792	86	Q3KQV3
RPGFRVCYICGREFG	ZNF474	91	Q6S9Z5
GAFDPVCAFIRVGYH	SEMA3E	136	O15041
YAGFPGCGLLRLHST	PPIP5K2	541	O43314
YPREGKYGHAACFGL	THOP1	416	P52888
GDYAGFPGCGLLRLH	PPIP5K1	551	Q6PFW1
EVFPGRNRFYCGGRL	ZDHHC18	71	Q9NUE0
GYSLRHQCPRCPRGF	ZBTB6	296	Q15916
RFRYVCEGPSHGGLP	NFKB1	56	P19838
FRFRYGCEGPSHGGL	NFKB2	51	Q00653